Skip to content

Pilsicainide

Drug profile

Also known as: pilsicainide HCl, pilsicainide hydrochloride, pilsicainide hydrochloride hemihydrate, pilsicainide hydrochloride hydrate, pilzicainide, SUN 1165

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Pilsicainide is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including KCNH2 and SCN4A. Recorded indications include Tachyarrhythmia.

  • Molecular targets: KCNH2 and SCN4A (2 listed in DrugCentral).
  • Indications: Tachyarrhythmia.
  • Molecular formula: C17H24N2O; molecular weight 272.39 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Tachyarrhythmia

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Potassium voltage-gated channel subfamily H member 2KCNH2unknownIC50 4.69
Sodium channel protein type 4 subunit alphaSCN4AblockerIC50 4.38

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Cerebral infarction83.3
Cardiac failure47.7
Renal impairment44.8
Atrial fibrillation44.6
Cardiac tamponade43.7
Interstitial lung disease39.1

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Pilsicainide is on its molecule page.

Molecular formulaC17H24N2O
Molecular weight272.39 g/mol
CAS number88069-67-4
InChIKeyBCQTVJKBTWGHCX-UHFFFAOYSA-N
PubChem CID4820
CC1=CC=CC(C)=C1NC(=O)CC12CCCN1CCC2

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Pilsicainide used for?

DrugCentral lists the following indications for Pilsicainide: Tachyarrhythmia.

How does Pilsicainide work?

Its molecular targets in DrugCentral include KCNH2 and SCN4A (blocker).

What is the chemical formula of Pilsicainide?

Pilsicainide has the molecular formula C17H24N2O and a molecular weight of 272.39 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets2
Indications1
FormulaC17H24N2O
DrugCentral ID2167
Interactive profile